Articles & Publications , Thierry Van Nieuwenhove

Thierry Van Nieuwenhove comments on the future of Pharma Manufacturing

In this article by Manufacturing Chemist, Thierry Van Nieuwenhove, CEO of Quotient Sciences, discusses the future of pharma manufacturing.

Ahead of the upcoming DCAT, Dr. Kevin Robinson caught up with pharmaceutical industry experts to discuss how they’re innovating for resilience and sustainability in 2025 and beyond.

Thierry Van Nieuwenhove, CEO of Quotient Sciences recognizes that sustainability and resilience are critical to the future of pharmaceutical development supply chains.

Continue reading the full article on Manufacturing Chemist.

Latest news from Quotient Sciences

More News

News & Announcements, Articles & Publications, Philadelphia, PA, Marlene Leuenberger Marlene Leuenberger featured in CPHI Online's "A Day in the Life of a Vice President and General Manager" By: Marlene Leuenberger

Articles & Publications, News & Announcements, Dr. Andrew Lewis Dr. Andrew Lewis Contributes to The Medicine Maker's "How Speed, Scale, and Science Can Personalize the Pandemic Response" By: Dr. Andy Lewis

Articles & Publications, News & Announcements, John McDermott Accelerating Innovation: AI Drives 50% Faster Formulation Development By: John McDermott

More News

Your breakthrough therapy deserves momentum, and every day matters. Start a conversation with us today.